[1] WHO. Global tuberculosis report 2016[R]. Geneva:WHO, 2016.
[2] THÉRY C. Exosomes:secreted vesicles and intercellular communications[J]. F1000 Biol Rep, 2011, 3:15.
[3] KRUH-GARCIA N A, SCHOREY J S, DOBOS K M. Exosomes:new tuberculosis biomarkers-prospects from the bench to the clinic[R]. Rijeka:INTECH Open Access Publisher, 2012.
[4] RAPOSO G, STOORVOGEL W. Extracellular vesicles:exosomes, microvesicles, and friends[J]. J Cell Biol, 2013, 200(4):373-383.
[5] LIN J, LI J, HUANG B, et al. Exosomes:novel biomarkers for clinical diagnosis[J]. Sci World J, 2015, 2015:657086.
[6] TICKNER J A, URQUHART A J, STEPHENSON S A, et al. Functions and therapeutic roles of exosomes in cancer[J]. Front Oncol, 2014, 4:127.
[7] ALIPOOR S D, MORTAZ E, TABARSI P, et al. Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages[J]. J Transl Med, 2017, 15:105.
[8] MORTAZ E, ALIPOOR S D, TABARSI P, et al. The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing[J]. Int J Mycobacteriol, 2016, 5(Suppl 1):S184-S185.
[9] LEE J, KIM S H, CHOI D S, et al. Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis[J]. Proteomics, 2015, 15(19):3331-3337.
[10] SUN T, KALIONIS B, LV G Y, et al. Role of exosomal noncoding RNAs in lung carcinogenesis[J]. Bio Med Res Int, 2015, 2015:125807.
[11] ELDH M. Exosomes and exosomal RNA-a way of cell-to-cell communication[D]. Gothenburg:University of Gothenburg, 2013.
[12] KOUREMBANAS S. Exosomes:vehicles of intercellular signaling, biomarkers, and vectors of cell therapy[J]. Annu Rev Physiol, 2015, 77:13-27.
[13] CHENG Y, SCHOREY J S. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection[J]. Eur J Immunol, 2013, 43(12):3279-3290.
[14] XU S, COOPER A, STURGILL-KOSZYCKI S, et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages[J]. J Immunol, 1994, 153(6):2568-2578.
[15] WANG J J, CHEN C, XIE P F, et al. Proteomic analysis and immune properties of exosomes released by macrophages infected with Mycobacterium avium[J]. Microbes Infect, 2014, 16(4):283-291.
[16] RAMACHANDRA L, QU Y, WANG Y, et al. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class Ⅱ molecules capable of antigen presentation[J]. Infect Immun, 2010, 78(12):5116-5125.
[17] ANAND P K, ANAND E, BLECK C K E, et al. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria[J]. PLoS One, 2010, 5(4):e10136.
[18] SCHOREY J S, BHATNAGAR S. Exosome function:from tumor immunology to pathogen biology[J]. Traffic, 2008, 9(6):871-881.
[19] WANG J J, YAO Y L, XIONG J, et al. Evaluation of the inflammatory response in macrophages stimulated with exosomes secreted by Mycobacterium avium-infected macrophages[J]. BioMed Res Int, 2015, 2015:658421.
[20] SMITH V L, CHENG Y, BRYANT B R, et al. Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection[J]. Sci Rep, 2017, 7:43578.
[21] GIRI P K, KRUH N A, DOBOS K M, et al. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages[J]. Proteomics, 2010, 10(17):3190-3202.
[22] KRUH-GARCIA N A, WOLFE L M, DOBOS K M. Deciphering the role of exosomes in tuberculosis[J]. Tuberculosis (Edinb), 2015, 95(1):26-30.
[23] SINGH P P, LEMAIRE C, TAN J C, et al. Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages[J]. PLoS One, 2011, 6(4):e18564.
[24] MORTAZ E, ALIPOOR S D, TABARSI P, et al. The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing[J]. Int J Mycobacteriol, 2016, 5(S1):S184-S185.
[25] SINGH P P, LI L, SCHOREY J S. Exosomal RNA from Mycobacterium tuberculosis-infected cells is functional in recipient macrophages[J]. Traffic, 2015, 16(6):555-571.
[26] MARTIN C J, CAREY A F, FORTUNE S M. A bug's life in the granuloma[J]. Semin Immunopathol, 2016, 38(2):213-220.
[27] WALLIS R S, PAI M, MENZIES D, et al. Biomarkers and diagnostics for tuberculosis:progress, needs, and translation into practice[J]. Lancet, 2010, 375(9729):1920-1937.
[28] MAERTZDORF J, KAUFMANN S H E, WEINER Ⅲ J. Toward a unified biosignature for tuberculosis[J]. Cold Spring Harb Perspect Med, 2014, 5(1):a018531.
[29] UEBERBERG B, KOHNS M, MAYATEPEK E, et al. Are microRNAs suitable biomarkers of immunity to tuberculosis?[J]. Mol Cell Pediatr, 2014, 1:8.
[30] WALZL G, HAKS M C, JOOSTEN S A, et al. Clinical immunology and multiplex biomarkers of human tuberculosis[J]. Cold Spring Harb Perspect Med, 2014, 5(4):a018515.
[31] STAALS R H J, PRUIJN G J M. The human exosome and disease[M]//JENSEN T H. RNA Exosome. New York, NY:Springer, 2010:132-142.
[32] BEATTY W L, RHOADES E R, ULLRICH H J, et al. Trafficking and release of mycobacterial lipids from infected macrophages[J]. Traffic, 2000, 1(3):235-247.
[33] SIMPSON R J, LIM J W, MORITZ R L, et al. Exosomes:proteomic insights and diagnostic potential[J]. Expert Rev Proteomics, 2009, 6(3):267-283.
[34] FUJITA Y, KOSAKA N, ARAYA J, et al. Extracellular vesicles in lung microenvironment and pathogenesis[J]. Trends Mol Med, 2015, 21(9):533-542.
[35] LÄSSER C. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors[J]. Expert Opin Biol Ther, 2012, 12(Suppl 1):S189-S197.
[36] SCHOREY J S, CHENG Y, SINGH P P, et al. Exosomes and other extracellular vesicles in host-pathogen interactions[J]. EMBO Rep, 2015, 16(1):24-43.
[37] LIN J, WANG Y, ZOU Y Q, et al. Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia[J]. Tumor Biol, 2016, 37(12):15835-15845.
[38] LV L N, LI C D, ZHANG X L, et al. RNA profiling analysis of the serum exosomes derived from patients with active and latent mycobacterium tuberculosis infection[J]. Front Microbiol, 2017, 8:1051.
[39] WANG Y, XU Y M, ZOU Y Q, et al. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions[J]. Medicine (Baltimore), 2017, 96(44):e8361.
[40] KRUH-GARCIA N A, WOLFE L M, CHAISSON L H, et al. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS[J]. PLoS One, 2014, 9(7):e103811.
[41] MEHAFFY C, DOBOS K M, NAHID P, et al. Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum[J]. Clin Proteomics, 2017, 14:21.
[42] DIAZ G, WOLFE L M, KRUH-GARCIA N A, et al. Changes in the membrane-associated proteins of exosomes released from human macrophages after Mycobacterium tuberculosis infection[J]. Sci Rep, 2016, 6:37975.
[43] QAZI K R, TORREGROSA PAREDES P, DAHLBERG B, et al. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis[J]. Thorax, 2010, 65(11):1016-1024.
[44] SCHOREY J S, DOBOS K M. Exosomes and diagnostic biomarkers:USA, 9255924[P]. 2016-02-09.
[45] MITTELBRUNN M, GUTIÉRREZ-VÁZQUEZ C, VILLARROYA-BELTRI C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells[J]. Nat Commun, 2011, 2:282.
[46] JOHNSTONE R M. Exosomes biological significance:a concise review[J]. Blood Cells Mol Dis, 2006, 36(2):315-321.
[47] DELCAYRE A, SHU H, LE PECQ J B. Dendritic cell-derived exosomes in cancer immunotherapy:exploiting nature's antigen delivery pathway[J]. Expert Rev Anticancer Ther, 2005, 5(3):537-547.
[48] DE TORO J, HERSCHLIK L, WALDNER C, et al. Emerging roles of exosomes in normal and pathological conditions:new insights for diagnosis and therapeutic applications[J]. Front Immunol, 2015, 6:203.
[49] KOYAMA Y, ITO T, HASEGAWA A, et al. Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen:a novel vaccine for cancer therapy[J]. Biotechnol Lett, 2016, 38(11):1857-1866.
[50] CHENG Y, SCHOREY J S. Targeting soluble proteins to exosomes using a ubiquitin tag[J]. Biotechnol Bioeng, 2016, 113(6):1315-1324.
[51] SMITH V L, JACKSON L, SCHOREY J S. Ubiquitination as a mechanism to transport soluble mycobacterial and eukaryotic proteins to exosomes[J]. J Immunol, 2015, 195(6):2722-2730.
[52] WU S C, YANG J C S, RAU C S, et al. Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture[J]. PLoS One, 2013, 8(10):e77936.
[53] CANITANO A, VENTURI G, BORGHI M, et al. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs[J]. Cancer Lett, 2013, 337(2):193-199.
[54] NARAYANAN A, IORDANSKIY S, DAS R, et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA[J]. J Biol Chem, 2013, 288(27):20014-20033. |